<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0030">
 <label>6</label>
 <element-citation publication-type="journal" id="h0030">
  <person-group person-group-type="author">
   <name>
    <surname>Tahtinen</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Feola</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Capasso</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Laustio</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Groeneveldt</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Ylosmaki</surname>
    <given-names>E.O.</given-names>
   </name>
  </person-group>
  <article-title>Exploiting pre-existing immunity to enhance oncolytic cancer immunotherapy</article-title>
  <source>Cancer Res</source>
  <year>2020</year>
 </element-citation>
</ref>
